| Date | Title | Description |
| 12.05.2023 | 11 investors predict a colorful, if difficult, future for psychedelic startups | How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look.
If you look at the stock market, the view isn’t very good: the charts are all down and in the red, and all you can see are psy... |
| 16.03.2023 | Meet the top 14 VCs who've bet the most cash on turning psychedelics into medical treatments | Sean McLintock, Sonia Weiss Pick, Michael Sobeck, and Nikolay Tretiyakov Neo Kuma Ventures, WPSS.bio, Ambria Capital, Leafly Tunnel, Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start re... |
| 02.07.2022 | Retail investors or guinea pigs? | Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here.
There is a paradox when it comes to reta... |
| 20.04.2022 | How CBD biomanufacturing could make Europe change and win the cannabis game | By now, many have heard about Cannabidiol, better known as CBD, the non-psychoactive cannabinoid derived from the cannabis plant and discovered in 1940. You can find it in products ranging from edible gummy bears to skin oil, for purposes s... |
| 17.12.2021 | Maya Health Raises $4.3 Million to Decentralize Psychedelic Medicine Research | The implementation of Maya Health for our practice has allowed us greater visibility into where our clients are on their healing journey.
DENVER (PRWEB) December 17, 2021
Today, Maya Health (Maya PBC), the leading real-world data platform c... |
| 16.08.2021 | Psychedelic mushrooms to treat rare headache: Oxford startup lands $80M | Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, today announced it has successfully completed an oversubscribed Series B financing, ra... |
| - | How CBD biomanufacturing could make Europe change and win the cannabis game | By now, many have heard about Cannabidiol, better known as CBD, the non-psychoactive cannabinoid derived from the cannabis plant and discovered in 1940. You can find it in products ranging from edible gummy bears to skin oil, for purposes s... |
| - | Psychedelic mushrooms to treat rare headache: Oxford startup lands $80M | Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, today announced it has successfully completed an oversubscribed Series B financing, ra... |